| Dr Lawrence Tambling Kent, MD | |
|
1611 S Green Rd, Suite 260, South Euclid, OH 44121-4128 | |
| (216) 381-6177 | |
| (216) 297-2117 |
| Full Name | Dr Lawrence Tambling Kent |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 50 Years |
| Location | 1611 S Green Rd, South Euclid, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346284296 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 35-04-1629 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Hospitals Medical Group Inc | 4789682493 | 1466 |
News Archive
The Australian scientist who won a Nobel Prize for identifying a cancer-causing stomach bacterium, today said a clinical trial had shown that some strains of the bacteria (Helicobacter pylori or H. pylori) were safe and well tolerated in humans.
A new study on the smokeless tobacco product called moist snuff - placed between lip and gum - has led scientists in Minnesota to urge the tobacco industry to change manufacturing practices to reduce snuff's content of carcinogens.
Even as California prepares to expand vaccine eligibility on April 15 to all residents age 16 and up, the state has managed to inoculate only about half its senior population — the 65-and-older target group deemed most vulnerable to death and serious illness in the pandemic.
GlaxoSmithKline (GSK) has announced that its new drug application (NDA) for ORAL HYCAMTIN (topotecan) capsules, a treatment for relapsed small cell lung cancer (SCLC), has been granted Priority Review by the United States Food and Drug Administration (FDA).
› Verified 4 days ago
| Entity Name | University Primary Care Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
The Australian scientist who won a Nobel Prize for identifying a cancer-causing stomach bacterium, today said a clinical trial had shown that some strains of the bacteria (Helicobacter pylori or H. pylori) were safe and well tolerated in humans.
A new study on the smokeless tobacco product called moist snuff - placed between lip and gum - has led scientists in Minnesota to urge the tobacco industry to change manufacturing practices to reduce snuff's content of carcinogens.
Even as California prepares to expand vaccine eligibility on April 15 to all residents age 16 and up, the state has managed to inoculate only about half its senior population — the 65-and-older target group deemed most vulnerable to death and serious illness in the pandemic.
GlaxoSmithKline (GSK) has announced that its new drug application (NDA) for ORAL HYCAMTIN (topotecan) capsules, a treatment for relapsed small cell lung cancer (SCLC), has been granted Priority Review by the United States Food and Drug Administration (FDA).
› Verified 4 days ago
| Entity Name | University Hospitals Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
The Australian scientist who won a Nobel Prize for identifying a cancer-causing stomach bacterium, today said a clinical trial had shown that some strains of the bacteria (Helicobacter pylori or H. pylori) were safe and well tolerated in humans.
A new study on the smokeless tobacco product called moist snuff - placed between lip and gum - has led scientists in Minnesota to urge the tobacco industry to change manufacturing practices to reduce snuff's content of carcinogens.
Even as California prepares to expand vaccine eligibility on April 15 to all residents age 16 and up, the state has managed to inoculate only about half its senior population — the 65-and-older target group deemed most vulnerable to death and serious illness in the pandemic.
GlaxoSmithKline (GSK) has announced that its new drug application (NDA) for ORAL HYCAMTIN (topotecan) capsules, a treatment for relapsed small cell lung cancer (SCLC), has been granted Priority Review by the United States Food and Drug Administration (FDA).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lawrence Tambling Kent, MD 1611 S Green Rd, Suite 260, South Euclid, OH 44121-4128 Ph: (216) 381-6177 | Dr Lawrence Tambling Kent, MD 1611 S Green Rd, Suite 260, South Euclid, OH 44121-4128 Ph: (216) 381-6177 |
News Archive
The Australian scientist who won a Nobel Prize for identifying a cancer-causing stomach bacterium, today said a clinical trial had shown that some strains of the bacteria (Helicobacter pylori or H. pylori) were safe and well tolerated in humans.
A new study on the smokeless tobacco product called moist snuff - placed between lip and gum - has led scientists in Minnesota to urge the tobacco industry to change manufacturing practices to reduce snuff's content of carcinogens.
Even as California prepares to expand vaccine eligibility on April 15 to all residents age 16 and up, the state has managed to inoculate only about half its senior population — the 65-and-older target group deemed most vulnerable to death and serious illness in the pandemic.
GlaxoSmithKline (GSK) has announced that its new drug application (NDA) for ORAL HYCAMTIN (topotecan) capsules, a treatment for relapsed small cell lung cancer (SCLC), has been granted Priority Review by the United States Food and Drug Administration (FDA).
› Verified 4 days ago
Dr. Thomas Joseph King, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1611 S Green Rd, Suite 260, South Euclid, OH 44121 Phone: 216-382-5214 Fax: 216-382-9345 | |
Dr. Steven Turoczi, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1611 S Green Rd Ste 160, South Euclid, OH 44121 Phone: 216-691-3518 Fax: 216-297-3156 | |
Dr. Lydia L. Burrell, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1611 S Green Rd, Suite 160, South Euclid, OH 44121 Phone: 216-297-3070 Fax: 216-297-3156 | |
Dr. James Michael Coviello, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1611 S Green Rd, Suite 160, South Euclid, OH 44121 Phone: 216-691-3510 Fax: 216-297-3077 | |
Dr. William Wayne Steiner, M.D.; PH.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1611 S Green Rd, Suite 260, South Euclid, OH 44121 Phone: 216-382-2036 Fax: 216-297-2117 | |
Dr. Andrew Duncan Grant, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 4110 Stilmore Rd, South Euclid, OH 44121 Phone: 216-938-9524 | |
Nadia Umar Mansour, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1611 S Green Rd Ste 200, South Euclid, OH 44121 Phone: 440-708-1555 Fax: 440-708-1515 |